Find and Join

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

• Education (and CE) from USP

  For the fourth year in a row, USP will be holding a hybrid live/virtual workshop dedicated to improving the quality of compounding. read more →

• Compounding post-Chevron

  At least three issues affecting pharmacy compounding might be affected by the overturning of the decades-old “Chevron doctrine.” read more →

• 503B sourcing: our state-by-state analysis

  Do you work for one of APC’s PFMs? If you’re with a Pharmacy/Facility Member, you’ve got access to a new resource. read more →

• What we’ll be talking about at CCH

  When we get together on Capitol Hill to meet with legislators and their staffs, as much as we’d like to talk about a half-dozen issues (easily!), we’re going to be focusing on the three most important.  read more →

More News

For years, other voices have been telling the story of pharmacy compounding—to the world, at FDA, on Capitol Hill, even to state boards of pharmacy. Their telling is of an unregulated industry, harming patients, intent on only making money.

We know that’s not remotely true, but until now, we’ve lacked the voice and resources to tell our own story.

That’s about to change.

It’s time for us to tell America about the life-enhancing, life-saving impact you have on your patients.

On February 16, we’ll tell you about ‘Compounding the Joy of Living: The Campaign for Pharmacy Compounding.’

It’s us taking control of our own destiny.

Compounding the Joy is the third year of our 3-year media campaign to protect compounding. We initially focused on hormones (and that fight continues) but we are expanding our mandate to secure the future of all compounding.

Join us on February 16 for a Virtual Town Hall. We’ll walk you through the campaign and share with you the story we aim to tell—your story. We’ll also tell you how your involvement will help secure the future of the compounding profession.

Only together can we hope to secure that future—for our patients, for our businesses, for our communities.